Intra-lymphatic administration of GAD-alum in type 1 diabetes: long-term follow-up and effect of a late booster dose (the DIAGNODE Extension trial)

AIM: To evaluate the long-term effect of intra-lymphatic administration of GAD-alum and a booster dose 2.5 years after the first intervention (DIAGNODE Extension study) in patients with recent-onset type 1 diabetes. METHODS: DIAGNODE-1: Samples were collected from 12 patients after 30 months who had...

Descripción completa

Detalles Bibliográficos
Autores principales: Casas, Rosaura, Dietrich, Fabrícia, Puente-Marin, Sara, Barcenilla, Hugo, Tavira, Beatriz, Wahlberg, Jeannette, Achenbach, Peter, Ludvigsson, Johnny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995247/
https://www.ncbi.nlm.nih.gov/pubmed/35098372
http://dx.doi.org/10.1007/s00592-022-01852-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995247/
https://www.ncbi.nlm.nih.gov/pubmed/35098372
http://dx.doi.org/10.1007/s00592-022-01852-9

Ejemplares similares